Published in Br Med J on November 06, 1976
Interaction of Ethambutol with human organic cation transporters of the SLC22 family indicates potential for drug-drug interactions during antituberculosis therapy. Antimicrob Agents Chemother (2013) 0.84
Interstitial nephritis. J Clin Pathol (1981) 0.83
Characterization of 22 Antituberculosis Drugs for Inhibitory Interaction Potential on Organic Anionic Transporter Polypeptide (OATP)-Mediated Uptake. Antimicrob Agents Chemother (2016) 0.79
Antitubercular effect of 8-[(4-Chloro phenyl) sulfonyl]-7-Hydroxy-4-Methyl-2H-chromen-2-One in guinea pigs. J Pharmacol Pharmacother (2011) 0.75
Drug-induced lupus syndromes. Mayo Clin Proc (1969) 3.38
Acute renal failure after rifampicin: a case report and survey of the literature. Nephron (1976) 1.39
Clinical pharmacology of ethambutol. Am Rev Respir Dis (1963) 1.39
Peripheral neuropathy with ethambutol. Postgrad Med J (1972) 1.13
Ethambutol absorption, excretion and dosage in patients with renal tuberculosis. Chemotherapy (1970) 1.02
Hyperuricemia due to ethambutol. N Engl J Med (1972) 0.92
Ethambutol and a false-positive screening test for phaeochromocytoma. Br Med J (1972) 0.89
[Comparison between renal clearances with inulin and para-aminohippuric acid and blood concentrations of ethambutol]. Schweiz Med Wochenschr (1972) 0.83
Studies on the mechanism of ethambutol-induced hyperuricemia. Arthritis Rheum (1972) 0.82
Renal effects of antituberculous antibiotics. Pathol Microbiol (Basel) (1970) 0.82
Racial and sexual discrimination in the selection of students for London medical schools. Med Educ (1986) 12.23
Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet (1989) 7.69
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet (1992) 5.36
Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet (1997) 2.66
Determination of total body water in uraemic patients by bioelectrical impedance. Nephrol Dial Transplant (1993) 2.66
Simplified method for measuring compliance of superficial veins. Cardiovasc Res (1971) 2.65
Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension (1995) 2.54
Management of a restricted drugs policy in hospital: the first five years' experience. Lancet (1985) 2.54
Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol (1987) 2.34
Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest (1992) 2.26
Isolation and structural characterization of a cDNA clone encoding the human DNA repair protein for O6-alkylguanine. Proc Natl Acad Sci U S A (1990) 2.19
Vitamin B-6: food or medicine? The rules--and the politics--are different. BMJ (1998) 2.02
Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo. Cardiovasc Res (1989) 1.98
Paediatric prescribing: using unlicensed drugs and medicines outside their licensed indications. Br J Clin Pharmacol (1999) 1.96
Enalapril-induced cough. Lancet (1986) 1.86
Cramp: a review. J R Soc Med (1982) 1.82
Promotion by the British pharmaceutical industry, 1983-8: a critical analysis of self regulation. BMJ (1990) 1.81
Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens (1992) 1.77
Comparison of the pharmacokinetics of metronidazole in healthy female volunteers following either a single oral or intravenous dose. Br J Clin Pharmacol (1979) 1.76
Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension. Clin Sci Mol Med Suppl (1975) 1.66
Pharmacodynamics of propranolol in renal failure. Br Med J (1972) 1.58
Renal amyloidosis--a fourteen-year follow-up. Q J Med (1973) 1.56
Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol (1992) 1.51
Forearm blood flow responses to a nitric oxide synthase inhibitor in patients with treated essential hypertension. Cardiovasc Res (1994) 1.43
Treatment of resistant CAPD peritonitis by temporary discontinuation of peritoneal dialysis. Clin Nephrol (1989) 1.42
Observations on CEREBRAL HAEMORRHAGE DUE TO CAUSES OTHER THAN ARTERIOSCLEROSIS. Br Med J (1931) 1.41
Doctors and patients should sign prescriptions. BMJ (1998) 1.40
Drug company representatives and sales priorities. Lancet (1993) 1.39
Ethics committees. Wandsworth District Research Ethics Committee. Lancet (1996) 1.39
Questionnaire assessment of patients' attitudes and beliefs about asthma. Fam Pract (1986) 1.37
Predictors of mortality in hemodialysis patients. J Am Soc Nephrol (1993) 1.30
Distress and radiological investigations of the urinary tract in children. Eur J Pediatr (1996) 1.24
Hyponatraemia. Br J Hosp Med (1979) 1.21
Nitric oxide and cardiovascular control. Exp Physiol (1993) 1.21
Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. Hepatology (1992) 1.18
Second messenger role for NO widens to nervous and immune systems. Trends Pharmacol Sci (1989) 1.17
Acute erythroleukemia: evaluation of 48 cases with reference to classification, cell proliferation, cytogenetics, and prognosis. Am J Clin Pathol (1998) 1.14
Reversible encephalopathy and acute renal failure after cephaloridine. Br Med J (1970) 1.14
The child with a non-blanching rash: how likely is meningococcal disease? Arch Dis Child (2001) 1.13
Interventions for the prevention and management of neck/upper extremity musculoskeletal conditions: a systematic review. Occup Environ Med (2006) 1.12
Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin Exp Immunol (2008) 1.11
Endothelial "stunning" following a brief exposure to endotoxin: a mechanism to link infection and infarction? Cardiovasc Res (1996) 1.11
Raised complement in nephritis: prognostic significance. Lancet (1972) 1.09
Marital problems and sexual dysfunction: how are they related? Br J Psychiatry (1988) 1.07
Regional renal hypothermia. Br J Urol (1967) 1.05
Confusion over use of placebos in clinical trials. BMJ (1995) 1.05
Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent. Br J Clin Pharmacol (1976) 1.04
Plasma level and renal clearance of oxalate in normal subjects and in patients with primary hyperoxaluria or chronic renal failure or both. Clin Sci (Lond) (1979) 1.03
A survey of suicidal behaviour in the Mid-Essex area in 1972. J R Coll Physicians Lond (1976) 1.02
Nocardia asteroides infection--a transmissible disease. J Hosp Infect (1980) 1.01
Deceleration trauma to the heart and great vessels after road-traffic accidents. Br Med J (1970) 1.01
Fluid removal by haemofiltration in diuretic resistant cardiac failure. Br Heart J (1985) 1.01
Removal of metronidazole by haemodialysis. Br J Surg (1980) 1.00
Genetic epidemiological study of schizophrenia in Palau, Micronesia: prevalence and familiality. Am J Med Genet (1999) 1.00
Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection. J Viral Hepat (2001) 0.99
The effect of haematocrit on the resistivity of human blood at 37 degrees C and 100 kHz. Med Biol Eng (1975) 0.99
The reproducibility of endometrial volume acquisition and measurement with the VOCAL-imaging program. Ultrasound Obstet Gynecol (2002) 0.98
Local venous responses to endotoxin in humans. Circulation (1996) 0.98
Biology and clinical relevance of nitric oxide. BMJ (1994) 0.97
High resolution proton magnetic resonance spectroscopy of cyst fluids from patients with polycystic kidney disease. Biochim Biophys Acta (1992) 0.96
Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: an insight into the targeting of nitric oxide delivery. J Pharmacol Exp Ther (1995) 0.95
Economic evaluation alongside a phase II, multi-centre, randomised controlled trial of very early rehabilitation after stroke (AVERT). Cerebrovasc Dis (2008) 0.93
Dilator actions of arginine in human peripheral vasculature. Clin Sci (Lond) (1991) 0.93
Severe muscle cramp due to acute hypomagnesaemia in haemodialysis. Br Med J (1969) 0.92
Using multimedia for patient information--a program about nocturnal enuresis. Br J Urol (1998) 0.91
Injury prevention training: a cluster randomised controlled trial assessing its effect on the knowledge, attitudes, and practices of midwives and health visitors. Inj Prev (2004) 0.91
Parental involvement in paediatric cancer treatment decisions. Eur J Cancer Care (Engl) (2009) 0.91
Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients. Int J Pharm (2008) 0.91
Comparison of lignocaine-prilocaine cream and amethocaine gel for local analgesia before venepuncture in children. Acta Paediatr (1999) 0.89
Endothelium-derived relaxing factor is an endogenous vasodilator in man. Br J Pharmacol (1989) 0.88
Potent antitumour activity of a new class of tumour-specific killer cells. Nature (1997) 0.88
The pharmaceutical price regulation scheme: a time for change. Lancet (1985) 0.87
Letter: Beta-blockade in the presence of renal disease and hypertension. Br Med J (1974) 0.87
Carcinoma of the OEsophagus. Results of Deep X-Ray Treatment. Proc R Soc Med (1941) 0.86
Oral infection of weanling foals with an equine isolate of Lawsonia intracellularis, agent of equine proliferative enteropathy. J Vet Intern Med (2010) 0.86
Physiological importance of nitric oxide. BMJ (1991) 0.86
Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or non-specific effect? Clin Sci (Lond) (1995) 0.85
Penicillin and tetracycline sensitivity of Jamaican strains of gonococci. West Indian Med J (1974) 0.85
Vasodilatation to arachidonic acid in humans. An insight into endogenous prostanoids and effects of aspirin. Circulation (1995) 0.85
Fatal case of sorafenib-associated idiosyncratic hepatotoxicity in the adjuvant treatment of a patient with renal cell carcinoma. BMC Cancer (2012) 0.85
Single sample estimates of renal clearances. Br J Urol (1979) 0.84
An outbreak of Nocardia asteroides infection in a renal transplant unit. Q J Med (1981) 0.84
Defective repair of O6-methylguanine-DNA in primary Sjögren's syndrome patients predisposed to lymphoma. Ann Rheum Dis (1995) 0.84
Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival. Am J Kidney Dis (1993) 0.82
The vascular endothelium in diabetes and hypertension. J Hypertens Suppl (1992) 0.82
The importance of blood resistivity in the measurement of cardiac output by the thoracic impedance method. Med Biol Eng (1975) 0.82
The Clinical History and Morbid Anatomy of a Case of Generalized Sclerodermia with Severe Muscular Atrophy. Proc R Soc Med (1913) 0.82
alpha-Tocopherol concentrations in equine serum and cerebrospinal fluid after vitamin E supplementation. Vet Rec (2010) 0.81
Holding children still for procedures. Paediatr Nurs (1997) 0.81
Stored blood transfusion induces transient pulmonary arterial hypertension without impairing coagulation in an ovine model of nontraumatic haemorrhage. Vox Sang (2013) 0.81
Clinical use of minoxidil (Loniten). J R Soc Med (1981) 0.81